Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 30: 1784-1788, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, J. C.
Right arrow Articles by Brown, W. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, J. C.
Right arrow Articles by Brown, W. V.

Clinical Chemistry, Vol 30, 1784-1788, Copyright © 1984 by American Association for Clinical Chemistry

Precipitation of apo E-containing lipoproteins by precipitation reagents for apolipoprotein B

JC Gibson, A Rubinstein and WV Brown

We measured the solubility of apolipoprotein E (apo E) after precipitation, with heparin-Mn2+ or dextran sulfate-Mg2+, of lipoproteins containing apo B. Data from 46 randomly selected subjects suggest that apo E is readily precipitated by dextran sulfate-Mg2+, but that heparin-Mn2+ preferentially precipitates apo E associated with apo B-containing lipoproteins while leaving the apo E-containing fraction of high-density lipoproteins (HDL) in solution. In a more detailed analysis of three subjects, we measured the lipoprotein association of apo E by column chromatography on agarose beads, before and after its precipitation from plasma. This study confirmed the preferential solubility of apo E associated with HDL lipoproteins. Using plasma from two normolipidemic subjects, we maintained the heparin concentration at 1.30 g/L and varied the manganese concentration from 9.2 to 184 mmol/L. A 46 mmol/L concentration best separated apo E-containing HDL from apo B-containing lipoproteins. Thus, at these final concentrations, heparin- Mn2+ appears to precipitate the apo E associated with apo B-containing lipoproteins, leaving soluble most of the apo E associated with lipoproteins of HDL size.


The following articles in journals at HighWire Press have cited this article:


Home page
 J CARDIOVASC PHARMACOL THERHome page
E. T. Bairaktari, K. I. Seferiadis, and M. S. Elisaf
Evaluation of Methods for the Measurement of Low-Density Lipoprotein Cholesterol
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 2005; 10(1): 45 - 54.
[Abstract] [PDF]

Home page
 J. Lipid Res.Home page
J. S. Cohn, C. Rodriguez, H. Jacques, M. Tremblay, and J. Davignon
Storage of human plasma samples leads to alterations in the lipoprotein distribution of apoC-III and apoE
J. Lipid Res., August 1, 2004; 45(8): 1572 - 1579.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. R. Warnick, W. G. Miller, P. P. Waymack, and F. P. Anderson
Lack of Agreement of Homogeneous Assays with the Reference Method for LDL-Cholesterol May Not Indicate Unreliable Prediction of Risk for Cardiovascular Disease * Authors of the article cited above respond:
Clin. Chem., October 1, 2002; 48(10): 1812 - 1815.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. R. Warnick, M. Nauck, and N. Rifai
Evolution of Methods for Measurement of HDL-Cholesterol: From Ultracentrifugation to Homogeneous Assays
Clin. Chem., September 1, 2001; 47(9): 1579 - 1596.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
S. Usui, M. Nakamura, K. Jitsukata, M. Nara, S. Hosaki, and M. Okazaki
Assessment of Between-Instrument Variations in a HPLC Method for Serum Lipoproteins and Its Traceability to Reference Methods for Total Cholesterol and HDL-Cholesterol
Clin. Chem., January 1, 2000; 46(1): 63 - 72.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.